CN103689375A - Noodle formula suitable for diabetic patients and processing method of the noodle - Google Patents
Noodle formula suitable for diabetic patients and processing method of the noodle Download PDFInfo
- Publication number
- CN103689375A CN103689375A CN201210365763.7A CN201210365763A CN103689375A CN 103689375 A CN103689375 A CN 103689375A CN 201210365763 A CN201210365763 A CN 201210365763A CN 103689375 A CN103689375 A CN 103689375A
- Authority
- CN
- China
- Prior art keywords
- noodle
- noodles
- chickpea
- gluten
- chick
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000012149 noodles Nutrition 0.000 title claims abstract description 62
- 238000003672 processing method Methods 0.000 title claims abstract description 8
- 206010012601 diabetes mellitus Diseases 0.000 title abstract description 37
- 235000010523 Cicer arietinum Nutrition 0.000 claims abstract description 33
- 244000045195 Cicer arietinum Species 0.000 claims abstract description 33
- 108010068370 Glutens Proteins 0.000 claims abstract description 30
- 235000021312 gluten Nutrition 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 241000209140 Triticum Species 0.000 claims abstract description 26
- 235000021307 Triticum Nutrition 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 23
- 235000013312 flour Nutrition 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 25
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 25
- 210000002221 olecranon process Anatomy 0.000 claims description 23
- 235000005911 diet Nutrition 0.000 claims description 21
- 230000000378 dietary effect Effects 0.000 claims description 19
- 229910019142 PO4 Inorganic materials 0.000 claims description 18
- 239000002131 composite material Substances 0.000 claims description 18
- 235000021317 phosphate Nutrition 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 16
- 239000003513 alkali Substances 0.000 claims description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 12
- 239000010452 phosphate Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 8
- 238000009413 insulation Methods 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- -1 35 kilograms Inorganic materials 0.000 claims description 5
- 206010018473 Glycosuria Diseases 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 22
- 235000013305 food Nutrition 0.000 abstract description 14
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 8
- 235000018102 proteins Nutrition 0.000 abstract description 8
- 102000004169 proteins and genes Human genes 0.000 abstract description 8
- 108090000623 proteins and genes Proteins 0.000 abstract description 8
- 239000011651 chromium Substances 0.000 abstract description 7
- 229910052804 chromium Inorganic materials 0.000 abstract description 7
- 230000000291 postprandial effect Effects 0.000 abstract description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 5
- 239000011575 calcium Substances 0.000 abstract description 5
- 229910052791 calcium Inorganic materials 0.000 abstract description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 4
- 229910052742 iron Inorganic materials 0.000 abstract description 4
- 239000011707 mineral Substances 0.000 abstract description 4
- 235000010755 mineral Nutrition 0.000 abstract description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 3
- 150000001720 carbohydrates Chemical class 0.000 abstract description 3
- 235000014633 carbohydrates Nutrition 0.000 abstract description 3
- 235000019784 crude fat Nutrition 0.000 abstract description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 abstract description 3
- 235000008696 isoflavones Nutrition 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 239000011669 selenium Substances 0.000 abstract description 3
- 229910052711 selenium Inorganic materials 0.000 abstract description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract description 2
- 229930003268 Vitamin C Natural products 0.000 abstract description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 2
- 150000004676 glycans Chemical class 0.000 abstract description 2
- 229920001282 polysaccharide Polymers 0.000 abstract description 2
- 239000005017 polysaccharide Substances 0.000 abstract description 2
- 235000019154 vitamin C Nutrition 0.000 abstract description 2
- 239000011718 vitamin C Substances 0.000 abstract description 2
- 239000011701 zinc Substances 0.000 abstract description 2
- 229910052725 zinc Inorganic materials 0.000 abstract description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 abstract 1
- 229960004488 linolenic acid Drugs 0.000 abstract 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 abstract 1
- 238000000465 moulding Methods 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 201000009104 prediabetes syndrome Diseases 0.000 description 2
- 229960001052 streptozocin Drugs 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001280 Prediabetic State Diseases 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002384 drinking water standard Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 108010050792 glutenin Proteins 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000012633 leachable Substances 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 150000002669 lysines Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/109—Types of pasta, e.g. macaroni or noodles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to a staple-food noodle formula suitable for diabetic patients and a processing method of the noodle. Main raw materials of the noodle comprise chickpea powder, gluten powder and wheat flour, wherein the weight of the chickpea powder accounts for over 50% of the total weight of raw materials except water, and the gluten powder and the wheat flour provide mucedin, thus facilitating noodle moulding. The raw materials are weighed, mixed, kneaded to form dough, cooked, rolled, cut, dried, measured, packaged, and the like. The noodle is rich in proteins, crude fat, plant polysaccharides, linolenic acid, linoleic acid, isoflavone and various mineral substances such as calcium, iron, zinc, phosphor, chromium, selenium, etc., and is rich in vitamin C, vitamin B1, vitamin B2, vitamin E, and other nutrients. The content of available carbohydrates in the chickpea is only 36%, and therefore the chickpea belongs to food with low GI value, and the blood sugar rise is small after the diabetic patients eats the chickpea noodle, which is important for postprandial blood sugar control for the diabetic patients.
Description
Technical field
The present invention relates to a kind of noodle formula and processing method that chick-pea is main component of take, these noodles are suitable as diabetes patient's staple food, the invention belongs to processing of farm products and food processing technology field.
Background technology
Diabetes are absolute by insulin or relative hyposecretion and a kind of chronic endocrine metabolism disease that causes, cardinal symptom can be summarized as " three-many-one-little ", i.e. " many foods, many drinks, diuresis ", " losing weight ", the fatal complication such as diabetes also can cause infection, heart change, lose the sight of both eyes, cerebrovascular disease, renal failure, lower limb gangrene; According in September, 2010 Chinese Medical Association's diabetology branch statistics, China's total patient of diabetes patient number reaches more than 9,200 ten thousand, comprises prediabetes total number of persons and reaches more than 1.48 hundred million; World Health Organization's prophesy: the incidence of disease to diabetes in 2025 will turn over 3 times; Under current medical level, simple medication is somewhat expensive not only, and it is larger to control state of an illness difficulty; Dietary therapy is the basic skills for the treatment of diabetes, and its mechanism is effectively to control glucose by keeping on a diet, and then is reduce or delay one of key measure of various diabetic complications.
Xinjiang, China Hotan Prefecture is one of four large long-lived areas, the internationally recognized world; In people from Uygurs diet, conventionally take beef and mutton, dairy produce, high sugared melon and fruit as main, the food intake of so higher fatty acid, high protein, high heat, diabetes and cardiovascular and cerebrovascular disease are suffered from locality but few people; Health organization section of the United Nations finds after examination, because be mixed with chick-pea in their staple food, chick-pea has played the crux effect of balanced diet just, allows them away from diabetes and " three high diseases ", therefore at local chick-pea be otherwise known as " Long life bean "; Chick-pea belongs to high nutrition bean, be rich in the compositions such as multiple quality plant albumen and several amino acids, vitamin, isoflavones, thick dietary fiber and calcium, magnesium, iron, in addition in seed, also contain adenine, choline, inositol, starch, glucose etc., wherein true protein content is up to more than 28%, crude fat 5%, carbohydrate 61%, cellulose 4-6%, chick-pea contains ten several amino acids, and wherein 8 seed amino acids of needed by human all possess, and content is than exceeding in oat more than 2 times; In chick-pea, every hectogram protein is containing 16.0 grams, glutamic acid, 4.6 grams of leucines, 4.5 grams of lysines.
China's traditional medicine shows that chick-pea is remarkable in adjuvant therapy of diabetes, angiocardiopathy, the aspect effect such as enrich blood, replenish the calcium; Chromium is the part of GTF (GTF), in its glycometabolism at body and fat metabolism, plays an important role; Exactly because diabetic's insulin relatively or definitely not enough and cause glycometabolism, fat metabolism, protein metabolism disorder; Chick-pea contains trace element chromium, and it has control, reduces blood sugar, prevents and slow down the effect of the diabetes state of an illness and complication thereof diabetes; Also report lower than Healthy People relevant for diabetic's chromium content all over the world, 3 factors and the coordinative role between them are depended in the adjusting of blood sugar for human body metabolism, these 3 factors are pancreas islet acceptor, glucose tolerance acceptor and insulin; Human body chromium content reduces, and will cause insulin active to reduce, and acceptor quantity reduces, impaired glucose tolerance, thus cause diabetes; Edible chick-pea product can make insulin active and insulin receptor quantity in body all increase, thereby reaches the object of controlling blood sugar, improving diabetic symptom; The chromium element and the polyunsaturated fatty acid that in chick-pea, contain can promote cholesterol metabolic, prevent that lipid from depositing, reduce blood platelet coagulability, preventing thrombosis at liver and arterial wall, prevent the inflammatory reaction of injury of blood vessel face, blood vessel is had to good protective effect, can effectively prevent and slow down diabetic complication; A lot of blood sugar is high, the larger diabetic of fluctuating, and within edible chick-pea product 3 months, blood sugar is all controlled effectively, and its complication has also obtained effective prevention and has slowed down; In view of these functional characteristics of chick-pea, the present invention selects chick-pea as its primary raw material.
Gluten claims again active face strength flour, wheat gluten protein, be the native protein extracting from wheat flour, several amino acids, consist of, protein content is up to 75%~85%, containing 15 necessary seed amino acids of human body, is nutritious plant protein resource; Gluten has the characteristics such as viscosity, elasticity, extensibility, film forming and liposuction.; Gluten is a kind of good flour-dough improver, and addition is unrestricted, still improves the effective ways of phytoprotein content in food simultaneously; On instant noodles, longlife noodles and noodles are produced, add a certain amount of Gluten, can obviously improve the processing characteristicies such as the stretching resistance of goods, counter-bending power and compressive resistance, increase noodles toughness, add and be difficult for broken end man-hour, and resistance to immersion, heat-resisting; Eating mouth feel is smooth, do not stick to one's teeth, strength road, and nutritious.
Wheat flour is the main component of making noodles, and the starch that contains about 70% left and right and about 12% protein, also have the components such as a small amount of grease and mineral matter; In wheat gluten 80% is above is glutenin and alcohol soluble protein, is the main component of mucedin, relevant with the viscoplasticity of dough, in forming dough, plays Main Function; The intensity of mucedin and noodles is closely related with viscoplasticity, is the key component that is formed with certain mechanical strength noodles, very large on the mouthfeel impact of noodles.
In the present invention, the main purpose of adding wheat flour and Gluten is in order to utilize the albumen network structure of mucedin formation noodles wherein, improve protein in chick-pea and can not form the shortcoming of network, thereby improve noodles intensity, viscoplasticity and the mouthfeel that chick-pea is main component; The invention provides that a kind of to take chick-pea, Gluten, wheat flour etc. be primary raw material, be applicable to the noodle formula of diabetes patient; Through the blood sugar test of diabetes big white mouse, result show these noodles on the impact of postprandial blood sugar significantly lower than wheat noodles.
Summary of the invention
The object of the present invention is to provide a kind of diabetes patient's of being applicable to noodle formula, these noodles are to be primary raw material by chick-pea, Gluten, wheat flour, salt and water, add a small amount of dietary alkali and composite phosphate, through the experiment of diabetes big white mouse blood sugar, obtained a kind of noodle product of the diabetes patient's of being suitable as staple food; These noodles are rich in natural plant, eight seed amino acids of needed by human, crude fat, thick dietary fiber, plant function polysaccharide, linoleic acid, the leukotrienes that human body is easy to digest and absorb, and the mineral matter such as iron, zinc, phosphorus, calcium, chromium, selenium, be also rich in vitamin C, Cobastab
1, Cobastab
2with nutrients such as vitamin Es; Chick-pea has the good reputation of " coarse food grain in coarse food grain ", has nourishing, effects such as strengthening body immunity that improves the health, and chick-pea belongs to low GI value food, so chick-pea is particularly suitable for diabetes, high fat of blood and hypertensive patient, eats.
Of the present invention is that a kind of primary raw material is the noodles of olecranon bean powder, Gluten etc., and this noodle formula is: 50-95 kilogram of olecranon bean powder, Gluten 5-18 kilogram, wheat flour 0-50 kilogram, 2 kilograms of salt, 100 grams of dietary alkalis, 200 grams of composite phosphates, 35 kilograms, water; The processing method of these noodles is: load weighted olecranon bean powder, Gluten and wheat flour are put into mixer and add water stirring, dissolve respectively salt, dietary alkali and composite phosphate simultaneously with a small amount of water, after dissolving, in whipping process, add successively; Stir to form after dough, then be finished product after insulation slaking, roll-forming, cutting, dry, metering and packing.
Olecranon bean powder of the present invention is that chick-pea raw material was pulverized 60 mesh sieves and obtained after impurity elimination; Such grinding particle size has been taken into account the mouthfeel of noodles, simultaneously the fine nutritional labelings such as most protein, isoflavones, grease, dietary fiber, minerals and vitamins that retained in chick-pea; In chick-pea, be rich in selenium, iron, chromium, calcium, etc. mineral element from nutrition, made up the nutrient of needed by human, play the effect of enriched noodles health properties.
The Gluten adding in the present invention and wheat flour can make the muscle degree of noodles greatly increase, and especially in Gluten, protein content, up to 75%-80%, makes the nutritive value of noodles increase again when improving sensory of noodles.
Water of the present invention is the water that meets national drinking water standard; Dietary alkali of the present invention is edible sodium carbonate, and food stage composite phosphate formula (mass percent) is: calgon 55% sodium phosphate trimer 29%, sodium pyrophosphate 3%, sodium dihydrogen phosphate 13%; Adding dietary alkali and composite phosphate is mainly manifested in the improving effect of noodles: can improve the pH value of noodles, increase the dissolubility of globulin in olecranon bean powder, increase gluten biceps, reduce starch leachable; Strengthen noodles viscoplasticity, improve the processing characteristics of noodles, be convenient to roll-in and be processed into homogeneous, smooth surface, have the noodles of suitable muscle degree, thereby improve noodles surface smoothness, increase the boiling fastness of noodles, improve mouthfeel and the local flavor of noodles.
Primary raw material in the present invention is olecranon bean powder, because the utilized carbohydrate mass percent (butt) in chick-pea only has 36%, after the chick-pea noodles of diabetes patient and wheat noodles equivalent, edible rear blood sugar amplification significantly reduces, and this is highly beneficial to diabetes patient's health; The noodles that the present invention makes blood sugar amplification after edible reduces, this be also the staple foods such as bread, steamed bun, rice, wheat noodles can not and, thereby be suitable as diabetes patient's staple food.
The noodles that the present invention makes to the experiment of diabetes big white mouse reducing postprandial blood glucose are: SD big white mouse is purchased from Beijing Vital River Experimental Animals Technology Co., Ltd., adopt streptozotocin mycin (STZ) induction diabetes rat model (Hao Ying, Chai Ruihua etc. improvement Streptozotocin (STZ) induction rat diabetes model and method for breeding [J] thereof. Chinese traditional Chinese medicine academic periodical, 2008, (4): 784-785); Then according to big white mouse body weight, the various formula noodles that employing the inventive method of the different amounts of feeding are made; Before the meal, dock when 30min, 60min, 120min, 180min and get blood after the meal, adopt Roche vigor type blood glucose meter and test paper to measure blood glucose value; Utilize the trapezoidal integration processing in origin software to obtain area under blood sugar formation curve; Adopt the new summer range test of Deng Kenshi (P<0.05) in SAS9.2 to carry out difference analysis to different noodle formulas; The experimental result obtaining is as table 1.
Noodle formula (mass ratio):
A, wheat flour noodles: wheat flour 100, water 35; B, olecranon bean powder 50, wheat flour 50, water 35;
C, olecranon bean powder 82, Gluten 15, salt 2, dietary alkali 0.1, composite phosphate 0.2, water 35;
D, olecranon bean powder 90, Gluten 10, salt 2, dietary alkali 0.1, composite phosphate 0.2, water 35;
E, olecranon bean powder 95, Gluten 5, salt 2, dietary alkali 0.1, composite phosphate 0.2, water 35;
The comparison of table 1 different formulations noodles to the value added of diabetes big white mouse postprandial blood sugar
Noodle formula | Time m-blood glucose value TG-AUC (mmol*h/L) | Conspicuousness |
a | 14.07+6.09 | A |
b | 8.19+2.95 | B |
c | 7.26+4.00 | B |
d | 6.60+5.26 | B |
e | 6.73+4.31 | B |
Note: data all with mean value+standard deviation represent-, p < 0.05
Can find out, olecranon bean powder mass ratio in the formula except water account for more than 50% noodles to diabetes big white mouse postprandial blood sugar value added all significantly lower than wheat flour noodles data (p < 0.05); Thereby the staple food noodles that obtain according to formula provided by the present invention and processing method are to be applicable to diabetes patient, remarkable to controlling diabetes postprandial blood sugar effect.
The specific embodiment
embodiment mono-
Take respectively 35 kilograms, 50 kilograms of olecranon bean powderes, 5 kilograms of Glutens, 40 kilograms of wheat flours, 2 kilograms of salt, 100 grams of dietary alkalis, 200 grams of composite phosphates and water; Load weighted olecranon bean powder, Gluten and wheat flour are put into mixer and add water stirring, with a small amount of water, dissolve respectively salt, dietary alkali and composite phosphate simultaneously, after dissolving, in whipping process, add successively; Stir to form after dough, then be finished product after insulation slaking, roll-forming, cutting, dry, metering and packing.
embodiment bis-
Take respectively 60 kilograms of olecranon bean powderes, 10 kilograms of Glutens, 30 kilograms of wheat flours, 2 kilograms of salt, 100 grams of dietary alkalis, 200 grams of composite phosphates, 35 kilograms, water; Load weighted olecranon bean powder, Gluten are put into mixer and add water stirring, with a small amount of water, dissolve respectively salt, dietary alkali and composite phosphate simultaneously, after dissolving, in whipping process, add successively; Stir to form after dough, then be finished product after insulation slaking, roll-forming, cutting, dry, metering and packing.
embodiment tri-
Take respectively 70 kilograms of olecranon bean powderes, 10 kilograms of Glutens, 20 kilograms of wheat flours, 2 kilograms of salt, 100 grams of dietary alkalis, 200 grams of composite phosphates, 35 kilograms, water; Load weighted olecranon bean powder, Gluten and wheat flour are put into mixer and add water stirring, with a small amount of water, dissolve respectively salt, dietary alkali and composite phosphate simultaneously, after dissolving, in whipping process, add successively; Stir to form after dough, then be finished product after insulation slaking, roll-forming, cutting, dry, metering and packing.
embodiment tetra-
Take respectively 85 kilograms of olecranon bean powderes, 15 kilograms of Glutens, 2 kilograms of salt, 100 grams of dietary alkalis, 200 grams of composite phosphates, 35 kilograms, water; Load weighted olecranon bean powder, Gluten are put into mixer and add water stirring, with a small amount of water, dissolve respectively salt, dietary alkali and composite phosphate simultaneously, after dissolving, in whipping process, add successively; Stir to form after dough, then be finished product after insulation slaking, roll-forming, cutting, dry, metering and packing.
Claims (3)
1. applicable glycosuria people's noodle formula and a processing method, is characterized in that:
(1) noodle formula is: 50-95 kilogram of olecranon bean powder, Gluten 5-18 kilogram, wheat flour 0-50 kilogram, 2 kilograms of salt, 100 grams of dietary alkalis, 200 grams of composite phosphates, 35 kilograms, water;
(2) noodle processing method is: load weighted olecranon bean powder, Gluten and wheat flour are put into mixer and add water stirring, dissolve respectively load weighted salt, dietary alkali and composite phosphate simultaneously with a small amount of water, after dissolving, in whipping process, add successively;
(3) stir to form after dough, then be finished product after insulation slaking, roll-forming, cutting, dry, metering and packing.
2. olecranon bean powder according to claim 1, is characterized in that chick-pea pulverized 60 mesh sieves.
3. noodle formula according to claim 1, is characterized in that the olecranon bean powder in these chick-pea noodles accounts for the more than 50% of raw material gross mass in addition that dewaters.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210365763.7A CN103689375A (en) | 2012-09-27 | 2012-09-27 | Noodle formula suitable for diabetic patients and processing method of the noodle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210365763.7A CN103689375A (en) | 2012-09-27 | 2012-09-27 | Noodle formula suitable for diabetic patients and processing method of the noodle |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103689375A true CN103689375A (en) | 2014-04-02 |
Family
ID=50351163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210365763.7A Pending CN103689375A (en) | 2012-09-27 | 2012-09-27 | Noodle formula suitable for diabetic patients and processing method of the noodle |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103689375A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104305173A (en) * | 2014-09-25 | 2015-01-28 | 南京中医药大学 | Health food for diabetics and preparation method thereof |
CN104996909A (en) * | 2015-07-22 | 2015-10-28 | 山东省农业科学院农产品研究所 | Low protein sorghum noodles special for patients suffering diabetes or nephropathy and preparation method of low protein sorghum noodles |
CN108208572A (en) * | 2018-01-24 | 2018-06-29 | 淳安县神农中医药科技有限公司 | A kind of diabetes are quenched one's thirst dietotherapy noodles and its manufacture craft |
CN109287961A (en) * | 2018-11-14 | 2019-02-01 | 韶关学院 | A kind of auxiliary hyperglycemic crisp chip and preparation method thereof |
CN109463621A (en) * | 2018-11-19 | 2019-03-15 | 李凤 | A kind of hypoglycemic coarse cereal powder low in calories and its application |
CN111000136A (en) * | 2019-12-23 | 2020-04-14 | 重庆中面商贸(集团)有限公司 | Noodles assisting in reducing blood fat and making method thereof |
CN111000137A (en) * | 2019-12-23 | 2020-04-14 | 重庆中面商贸(集团)有限公司 | Nutritional noodles and preparation method thereof |
CN111436616A (en) * | 2020-04-30 | 2020-07-24 | 新绎健康管理有限公司 | Composition containing vitamins and minerals |
CN114651940A (en) * | 2022-04-20 | 2022-06-24 | 河南工业大学 | Preparation process of premixed flour of frozen and cooked coarse cereal noodles |
CN115843969A (en) * | 2022-12-14 | 2023-03-28 | 南昌大学 | Children noodle capable of preventing obesity and improving intestinal microecology and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1097093A (en) * | 1994-04-15 | 1995-01-11 | 新疆维吾尔自治区维吾尔医研究所 | Cicer arietinum flour product and processing method thereof |
CN1294863A (en) * | 1999-11-05 | 2001-05-16 | 黑龙江省大豆技术开发研究中心 | Instant soybean protein noodles and its production process |
CN1784983A (en) * | 2005-11-16 | 2006-06-14 | 孙常宪 | Method for producing wheat flour with functions of lowering blood-sugar and blood-fat |
CN101142988A (en) * | 2006-09-13 | 2008-03-19 | 范旻 | Sugar-free type intensified element chickpea powder |
CN101341972A (en) * | 2007-07-09 | 2009-01-14 | 西安汇源科技开发有限公司 | Food capable of regulating and controlling blood sugar and preparation method thereof |
CN102396670A (en) * | 2011-11-17 | 2012-04-04 | 河南云鹤食品有限公司 | Frozen and cooked noodle capable of being heated through microwave |
-
2012
- 2012-09-27 CN CN201210365763.7A patent/CN103689375A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1097093A (en) * | 1994-04-15 | 1995-01-11 | 新疆维吾尔自治区维吾尔医研究所 | Cicer arietinum flour product and processing method thereof |
CN1294863A (en) * | 1999-11-05 | 2001-05-16 | 黑龙江省大豆技术开发研究中心 | Instant soybean protein noodles and its production process |
CN1784983A (en) * | 2005-11-16 | 2006-06-14 | 孙常宪 | Method for producing wheat flour with functions of lowering blood-sugar and blood-fat |
CN101142988A (en) * | 2006-09-13 | 2008-03-19 | 范旻 | Sugar-free type intensified element chickpea powder |
CN101341972A (en) * | 2007-07-09 | 2009-01-14 | 西安汇源科技开发有限公司 | Food capable of regulating and controlling blood sugar and preparation method thereof |
CN102396670A (en) * | 2011-11-17 | 2012-04-04 | 河南云鹤食品有限公司 | Frozen and cooked noodle capable of being heated through microwave |
Non-Patent Citations (7)
Title |
---|
全智慧等: "鹰嘴豆的研究进展", 《时珍国医国药》 * |
史贤明主编: "《食品安全与卫生学》", 31 March 2003, 中国农业出版社 * |
李宏梁主编: "《食品添加剂安全与应用》", 31 August 2012, 化学工业出版社 * |
王中旺主编: "《中华面文化大典》", 31 January 2005, 经济日报出版社 * |
王向向等: "几种豆类的碳水化合物消化特性研究", 《河南工业大学学报(自然科学版)》 * |
白满英,刘桂花: "药膳食疗佳品鹰嘴豆", 《东方食疗与保健》 * |
韩长日等主编: "《食品添加剂生产与应用技术》", 31 July 2006, 中国石化出版社 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104305173A (en) * | 2014-09-25 | 2015-01-28 | 南京中医药大学 | Health food for diabetics and preparation method thereof |
CN104996909A (en) * | 2015-07-22 | 2015-10-28 | 山东省农业科学院农产品研究所 | Low protein sorghum noodles special for patients suffering diabetes or nephropathy and preparation method of low protein sorghum noodles |
CN108208572A (en) * | 2018-01-24 | 2018-06-29 | 淳安县神农中医药科技有限公司 | A kind of diabetes are quenched one's thirst dietotherapy noodles and its manufacture craft |
CN109287961A (en) * | 2018-11-14 | 2019-02-01 | 韶关学院 | A kind of auxiliary hyperglycemic crisp chip and preparation method thereof |
CN109463621A (en) * | 2018-11-19 | 2019-03-15 | 李凤 | A kind of hypoglycemic coarse cereal powder low in calories and its application |
CN111000136A (en) * | 2019-12-23 | 2020-04-14 | 重庆中面商贸(集团)有限公司 | Noodles assisting in reducing blood fat and making method thereof |
CN111000137A (en) * | 2019-12-23 | 2020-04-14 | 重庆中面商贸(集团)有限公司 | Nutritional noodles and preparation method thereof |
CN111436616A (en) * | 2020-04-30 | 2020-07-24 | 新绎健康管理有限公司 | Composition containing vitamins and minerals |
CN114651940A (en) * | 2022-04-20 | 2022-06-24 | 河南工业大学 | Preparation process of premixed flour of frozen and cooked coarse cereal noodles |
CN115843969A (en) * | 2022-12-14 | 2023-03-28 | 南昌大学 | Children noodle capable of preventing obesity and improving intestinal microecology and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103689375A (en) | Noodle formula suitable for diabetic patients and processing method of the noodle | |
CN101836709B (en) | Tartary buckwheat noodles and preparation method thereof | |
Alam et al. | Development of fiber enriched herbal biscuits: a preliminary study on sensory evaluation and chemical composition | |
CN104286849A (en) | Diabetes-specific enteral nutrition multi-polymerization agent | |
CN103493865B (en) | Cookies suitable for hypertension group and making method thereof | |
Lin et al. | Sensory and nutritional properties of chinese olive pomace based high fibre biscuit | |
CN103168812A (en) | Sugar-free tartary buckwheat biscuit and manufacture method thereof | |
CN101584440B (en) | Functionality instant water chestnut paste and making method thereof | |
CN110973613A (en) | Plant composite powder composition suitable for weight-losing crowd, product suitable for weight-losing crowd and application | |
CN103783391A (en) | Lotus root noodles and processing method thereof | |
CN103766752A (en) | Coarse grain noodles | |
CN103783392A (en) | Lotus leaf noodles and processing method thereof | |
CN108651900A (en) | A kind of weight losing meal-replacing stick and preparation method thereof rich in resistant starch | |
CN105249175A (en) | Whole nutrition powder capable of conditioning diet and diseases and preparation method thereof | |
CN108514090A (en) | It is a kind of using banana as weight losing meal-replacing stick of primary raw material and preparation method thereof | |
CN107996847A (en) | A kind of meat donkey growth promotion functional feed and preparation method and application | |
CN105981986A (en) | Laying hen feed with function of lowering fat content of eggs and preparation method of laying hen feed | |
CN102177941A (en) | Method for preparing superfine medlar health care biscuit | |
CN107711988A (en) | A kind of preparation method of the fluffy health care sugar-free biscuit of coarse cereals alkali | |
KR100945450B1 (en) | Functional noodles using egg, milk, rice and whole wheat | |
CN102423005B (en) | Production method of egg with low cholesterol, rich selenium, and rich chromium | |
CN109259073A (en) | A kind of low GI value composite flour | |
CN113907111A (en) | Sugar-controlling and lipid-lowering mung bean meal-replacing biscuit and preparation method thereof | |
CN114586973A (en) | Low-GI (glycemic index) total-nutrient meal replacement powder and preparation method thereof | |
CN107518273A (en) | A kind of compound congee of coarse cereal fruit and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140402 |
|
RJ01 | Rejection of invention patent application after publication |